Bixiye
QP35-25 Unique Benefit for Department of Transportation (DOT) Physicals
Taariikhda uu dhaqangalayo Barnaamijka: : Abr 09, 2025
Natiijooyinka Raadinta
Soo bandhiga 961 - 970 ee natiijooyinka 4831
Bixiye
QP34-25 MHCP Pharmacy Benefit Exclusion for Grafapex™, Ivra and Selarsdi™
Taariikhda uu dhaqangalayo Barnaamijka: : Abr 09, 2025
Bixiye
QP33-25 Commercial Pharmacy Benefit Exclusion for Bkemv™, Otulfi™, Pyzchiva®, Selarsdi™ and Ustekinumab-ttwe™
Taariikhda uu dhaqangalayo Barnaamijka: : Abr 09, 2025
Bixiye
QP32-25 Cotiviti to Begin Preventable Readmission Audits
Taariikhda uu dhaqangalayo Barnaamijka: : Abr 09, 2025
Bixiye
QP31-25 Peer-to-Peer Discussions for Denied Claims Ending
Taariikhda uu dhaqangalayo Barnaamijka: : Abr 09, 2025
Bixiye
P16-25 Medical Policy Updates: Coupe Health and Self-Funded Benefit Plans Managed by Blue Cross and Blue Shield of Alabama
Taariikhda uu dhaqangalayo Barnaamijka: : Abr 01, 2025
Bixiye
P15-25 New Claim Edits for Professional Lab Claims Missing Required Data
Taariikhda uu dhaqangalayo Barnaamijka: : Abr 01, 2025
Bixiye
2025 April Bulletins
Taariikhda uu dhaqangalayo Barnaamijka: : Abr 01, 2025
Bixiye
P19-25 New and Updated Reimbursement Policies
Taariikhda uu dhaqangalayo Barnaamijka: : Abr 01, 2025